Gliotoxin, a natural product with ferroptosis inducing properties

Huabin Chen1, Ruiyun Zhao1, Meng Ge1

  • 1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Bioorganic Chemistry
|February 21, 2023
PubMed

Insights

Gliotoxin, a mycotoxin from Aspergillus fumigatus, is identified as a potent ferroptosis inducer. This natural compound demonstrates significant anti-tumor activity, offering a new template for developing novel cancer therapeutics.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Gliotoxin is a mycotoxin with known pharmacological effects including anti-tumor properties.
  • Ferroptosis is a distinct form of programmed cell death driven by iron-dependent lipid peroxidation.
  • Targeting ferroptosis is a promising strategy to overcome chemotherapy resistance.

Purpose of the Study:

  • To investigate gliotoxin's role as an inducer of ferroptosis.
  • To evaluate the anti-tumor efficacy of gliotoxin.
  • To explore gliotoxin as a potential natural template for ferroptosis inducer drug design.

Main Methods:

  • Cell viability assays were performed to determine anti-tumor activity.
  • Characterization of gliotoxin as a ferroptosis inducer.

Main Results:

  • Gliotoxin exhibited strong anti-tumor activity with IC50 values of 0.24 μM in H1975 cells and 0.45 μM in MCF-7 cells at 72 hours.
  • Gliotoxin was confirmed to induce ferroptosis, a specific type of cell death.

Conclusions:

  • Gliotoxin acts as a ferroptosis inducer with significant anti-tumor effects.
  • Gliotoxin represents a promising natural compound for the development of new ferroptosis-inducing anti-cancer agents.